Video
Novel treatments for depression
Current Psychiatry. 2015 May;14(5)
Author and Disclosure Information
Dr. Goldberg is Clinical Professor of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York and Director, Affective Disorders Research Program, Silver Hill Hospital, New Canaan, Connecticut.
Joseph F. Goldberg, MD, discusses future treatments targeting the glutamate system, such as ketamine, for treatment-resistant mood disorders.